Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Wong

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Oral Oncology|July 13, 2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakiaStuart J Wong, Bruce Campbell, Becky Massey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced MelanomaAhmad A Tarhini, Sandra J Lee, Xiaoxue Li, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Radiation-induced remodeling of the T cell landscape in head and neck cancerAbdullah A Memon, Imaad Said, Ean Norenberg, et al.
The Lancet. Oncology|February 10, 2009
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II studyEzra E W Cohen, Darren W Davis, Theodore G Karrison, et al.
Ebiomedicine|June 7, 2022
A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiomeJoseph Zenga, Samantha Atkinson, Tina Yen, et al.
Cancer|May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)K Kian Ang, Amy Chen, Walter J Curran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2012
A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neckJonas A de Souza, Darren W Davis, Yujian Zhang, et al.
Journal for Immunotherapy of Cancer|August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobert L Ferris, Rom S Leidner, Christine H Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Oral Oncology|July 13, 2013
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakiaStuart J Wong, Bruce Campbell, Becky Massey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2018
E3611-A Randomized Phase II Study of Ipilimumab at 3 or 10 mg/kg Alone or in Combination with High-Dose Interferon-α2b in Advanced MelanomaAhmad A Tarhini, Sandra J Lee, Xiaoxue Li, et al.
Cancer Immunology, Immunotherapy : CII|April 15, 2026
Radiation-induced remodeling of the T cell landscape in head and neck cancerAbdullah A Memon, Imaad Said, Ean Norenberg, et al.
The Lancet. Oncology|February 10, 2009
Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II studyEzra E W Cohen, Darren W Davis, Theodore G Karrison, et al.
Ebiomedicine|June 7, 2022
A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiomeJoseph Zenga, Samantha Atkinson, Tina Yen, et al.
Cancer|May 10, 2012
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN)K Kian Ang, Amy Chen, Walter J Curran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 29, 2012
A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neckJonas A de Souza, Darren W Davis, Yujian Zhang, et al.
Journal for Immunotherapy of Cancer|August 25, 2025
Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinomaRobert L Ferris, Rom S Leidner, Christine H Chung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
Cancer|March 27, 2019
Validation of NRG oncology/RTOG-0129 risk groups for HPV-positive and HPV-negative oropharyngeal squamous cell cancer: Implications for risk-based therapeutic intensity trialsCarole Fakhry, Qiang Zhang, Maura L Gillison, et al.
Pageof 5